ArticleDermatology and therapy2025

The Safety, Tolerability, and Pharmacokinetics of ALT-BB4 (A Novel Recombinant Hyaluronidase): A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study in Healthy Volunteers.

Ji Su Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.